Academic Programs at the UCR School of Medicine
364
Current Medical Students
44%
Underrepresented in Medicine
52.5%
Socioeconomically or educationally disadvantaged
36.8%
First generation college student
69
Biomedical Sciences Grad Students
127
Residents & Fellows
Featured Videos
Highlights of
Match Day 2025
Drone Flythough
of Education Building II
News from the School of Medicine
September 26, 2025
Healthy Aging Month: Embracing wellness at every age
UCR Health’s Dr. Alia Tuqan shares tips on staying healthy, active, and connected as we age
September 25, 2025
Childhood concussions may trigger long-term brain changes
Researchers call for extended care and monitoring after pediatric head injuries
September 24, 2025
UCR SOM Participates in 2025 Rally for Medical Research
A UCR School of Medicine delegation traveled to Washington, D.C., to participate in the Rally for Medical Research on September 18, 2025. The UCR delegation was part of more than 400 researchers and experts who visited congressional offices to advocate for sustained investment in medical research.
September 24, 2025
Physician honored with Arnold P. Gold Humanism in Medicine Award
Dr. Anita Gupta is recognized for advancing humanism, equity, and innovation in medicine
September 23, 2025
NIH grant supports research on dangerous emerging virus
International team to study immune defenses against Crimean-Congo hemorrhagic fever virus
September 23, 2025
Real Patient Data, Real Research, Real Impact: Innovation in Teaching Research with TriNetX
Recent student research projects at the UCR School of Medicine have investigated nationwide trends in contraceptive use, the link between blood pressure medications and pre-cancerous skin conditions, the development of Alzheimer's disease among patients with post-traumatic stress disorder (PTSD) in minority communities, and more.
The common element? The projects rely on TriNetX, a platform that provides access to extensive real-world patient data.
September 17, 2025
UCR startup secures grant to advance cancer therapy
NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer